☆ 4.7 Article

89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma

Hussein A. Tawbi et al.

Summary: LAG-3 and PD-1 are two distinct inhibitory immune checkpoints that contribute to T-cell exhaustion. The combination of relatlimab and nivolumab has been shown to be safe and effective in previously treated melanoma patients, and this study aimed to evaluate its safety and activity in previously untreated melanoma patients. The results demonstrated that the combination therapy provided a greater benefit in terms of progression-free survival compared to nivolumab alone, without any new safety signals.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Advantages and Applications of Total-Body PET Scanning

Sanaz Katal et al.

Summary: Total-body PET scanning has been studied in various fields and has advantages such as high detection sensitivity and long scan range. It can provide faster image acquisition with less radioactivity, and has potential applications in disease diagnosis, treatment response, and prognosis, aiming to improve patient care.

DIAGNOSTICS (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Study of 89Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non-Small Cell Lung Cancer

Anna-Larissa N. Niemeijer et al.

Summary: This study investigated the response of NSCLC patients to pembrolizumab monotherapy and the uptake of Zr-89-pembrolizumab in tumors, finding that patients with higher uptake had better responses to treatment. Although no significant correlation was found with PD-L1 or PD-1 immunohistochemistry, the injection of Zr-89-pembrolizumab was deemed safe in the study.

JOURNAL OF NUCLEAR MEDICINE (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm

Quentin Lecocq et al.

Summary: Blockade of immune checkpoints has advanced immuno-oncology, but not all patients benefit. Research on alternative pathways like LAG-3 shows promise as therapeutic targets. Monitoring LAG-3 expression in tumors is crucial for ongoing clinical trials.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals

Guus A. M. S. van Dongen et al.

Summary: The identification of molecular drivers of disease and the rise of biotherapeutics have impacted clinical care, but also presented challenges. The application of Zr-89-immuno-PET in drug development shows promise in guiding the design, development, and application of biologic drugs, with increasing potential for understanding drug-target combinations in clinical studies.

JOURNAL OF NUCLEAR MEDICINE (2021)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Single-Domain Antibody Nuclear Imaging Allows Noninvasive Quantification of LAG-3 Expression by Tumor-Infiltrating Leukocytes and Predicts Response of Immune Checkpoint Blockade

Quentin Lecocq et al.

Summary: Recent advances in immune-oncology have led to the discovery of next-generation immune checkpoints, with LAG-3 being a prime target for cancer treatment. Utilizing single-domain antibodies for molecular imaging allows for noninvasive monitoring of LAG-3 expression on tumor-infiltrating lymphocytes, which could be crucial for predicting therapy outcomes.

JOURNAL OF NUCLEAR MEDICINE (2021)

添加到收藏夹

Review Pathology

Gene of the month: lymphocyte-activation gene 3 (LAG-3)

Mark P. Lythgoe et al.

Summary: LAG-3 is a coreceptor found on activated T-lymphocytes, activated B-lymphocytes, and natural killer cells, closely related to CD4 and functioning as an inhibitor of T-cell signaling. Tumor-infiltrating lymphocytes with high LAG-3 expression have been found in various cancers, and LAG-3 antagonism is being explored as a potential anticancer therapy.

JOURNAL OF CLINICAL PATHOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Tertiary lymphoid structures improve immunotherapy and survival in melanoma

Rita Cabrita et al.

NATURE (2020)

添加到收藏夹

Article Pharmacology & Pharmacy

A novel cyclic peptide targeting LAG-3 for cancer immunotherapy by activating antigen-specific CD8+ T cell responses

Wenjie Zhai et al.

ACTA PHARMACEUTICA SINICA B (2020)

添加到收藏夹

Article Dentistry, Oral Surgery & Medicine

Prognostic value of tertiary lymphoid structure and tumour infiltrating lymphocytes in oral squamous cell carcinoma

Qunxing Li et al.

INTERNATIONAL JOURNAL OF ORAL SCIENCE (2020)

添加到收藏夹

Review Oncology

LAG-3: from molecular functions to clinical applications

Takumi Maruhashi et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

添加到收藏夹

Article Oncology

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures

Nicolas Gestermann et al.

ONCOIMMUNOLOGY (2020)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors

C. Willemien Menke-van der Houven van Oordt et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Interobserver reproducibility of tumor uptake quantification with 89Zr-immuno-PET: a multicenter analysis

Yvonne W. S. Jauw et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

89Zr-Immuno-PET: Toward a Noninvasive Clinical Tool to Measure Target Engagement of Therapeutic Antibodies In Vivo

Yvonne W. S. Jauw et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

添加到收藏夹

Article Biochemistry & Molecular Biology

Noninvasive Imaging of the Immune Checkpoint LAG-3 Using Nanobodies, from Development to Pre-Clinical Use

Quentin Lecocq et al.

BIOMOLECULES (2019)

添加到收藏夹

Article Oncology

Strategies for clinical development of monoclonal antibodies beyond first-in-human trials: tested doses and rationale for dose selection

Marie Viala et al.

BRITISH JOURNAL OF CANCER (2018)

添加到收藏夹

Article Immunology

Targeting LAG-3 and PD-1 to Enhance T Cell Activation by Antigen-Presenting Cells

Felix S. Lichtenegger et al.

FRONTIERS IN IMMUNOLOGY (2018)

添加到收藏夹

Article Biochemical Research Methods

Multiplex Immuno-Liquid Chromatography-Mass Spectrometry-Parallel Reaction Monitoring (LC-MS-PRM) Quantitation of CD8A, CD4, LAG3, PD1, PD-L1, and PD-L2 in Frozen Human Tissues

Qian Zhang et al.

JOURNAL OF PROTEOME RESEARCH (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch et al.

NATURE MEDICINE (2018)

添加到收藏夹

Article Multidisciplinary Sciences

Whole body PD-1 and PD-L1 positron emission tomography in patients with non-small-cell lung cancer

A. N. Niemeijer et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Article Oncology

Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma

Karina Silina et al.

CANCER RESEARCH (2018)

添加到收藏夹

Review Immunology

LAG3 (CD223) as a cancer immunotherapy target

Lawrence P. Andrews et al.

IMMUNOLOGICAL REVIEWS (2017)

添加到收藏夹

Article Oncology

LAG-3 Protein Expression in Non-Small Cell Lung Cancer and Its Relationship with PD-1/PD-L1 and Tumor-Infiltrating Lymphocytes

Yayi He et al.

JOURNAL OF THORACIC ONCOLOGY (2017)

添加到收藏夹

Review Oncology

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics

Lesley Seymour et al.

LANCET ONCOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints

Shohei Koyama et al.

NATURE COMMUNICATIONS (2016)

添加到收藏夹

Article Oncology

LAG-3 confers poor prognosis and its blockade reshapes antitumor response in head and neck squamous cell carcinoma

Wei-Wei Deng et al.

ONCOIMMUNOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Tissue-based map of the human proteome

Mathias Uhlen et al.

SCIENCE (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

The Molecular Signatures Database Hallmark Gene Set Collection

Arthur Liberzon et al.

CELL SYSTEMS (2015)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0

Ronald Boellaard et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)

添加到收藏夹

Article Immunology

Trafficking of LAG-3 to the Surface on Activated T Cells via Its Cytoplasmic Domain and Protein Kinase C Signaling

Joonbeom Bae et al.

JOURNAL OF IMMUNOLOGY (2014)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Multicenter Harmonization of 89Zr PET/CT Performance

Nikolaos E. Makris et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

添加到收藏夹

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

添加到收藏夹

Article Biochemical Research Methods

GSVA: gene set variation analysis for microarray and RNA-Seq data

Sonja Haenzelmann et al.

BMC BIOINFORMATICS (2013)

添加到收藏夹

Editorial Material Medicine, General & Internal

被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

添加到收藏夹

Article Immunology

Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma

Stephen R. Goding et al.

JOURNAL OF IMMUNOLOGY (2013)

添加到收藏夹

Article Biochemical Research Methods

RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome

Bo Li et al.

BMC BIOINFORMATICS (2011)

添加到收藏夹

Article Immunology

Differential subcellular localization of the regulatory T-cell protein LAG-3 and the coreceptor CD4

Seng-Ryong Woo et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2010)

添加到收藏夹

Article Biochemical Research Methods

Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine

Maria J. W. D. Vosjan et al.

NATURE PROTOCOLS (2010)

添加到收藏夹

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

添加到收藏夹

Article Immunology

LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis

Creg J. Workman et al.

JOURNAL OF IMMUNOLOGY (2009)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

How should we analyse FDG PET studies for monitoring tumour response?

Adriaan A. Lammertsma et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.